Down-regulation of T cell responses to AChR and reversal of EAMG manifestations in mice by a dual altered peptide ligand via induction of CD4+CD25+ regulatory cells

被引：12

作者：

Aruna, Badiga Venkata ^{[1
]}

Sela, Michael ^{[1
]}

Mozes, Edna ^{[1
]}

机构：

[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2006年 / 177卷 / 1-2期

关键词：

dual APL; EAMG; immunosuppression; CD4(+)CD25(+) regulatory cells; immunosuppressive cytokines;

D O I：

10.1016/j.jneuroim.2006.04.018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

A dual altered peptide ligand (APL) composed of the tandemly arranged two single amino acid analogs of two myasthenogenic peptides, p195-212 and p259-271 was demonstrated to down-regulate in vitro and in vivo myasthenia gravis (MG) associated autoreactive responses. In this study, we demonstrate the suppressive properties of the dual APL following immunization with the whole Torpedo AChR (TAChR) and in mice with established experimental autoimmune MG (EAMG). The dual APL acts by up-regulating CD4(+)CD25(+) cells expressing characteristic regulatory markers along with an associated increase in levels of IL-10 and TGF-beta. The latter cytokine plays a key role in the ameliorating effects of the dual APL. (c) 2006 Elsevier B.V. All rights reserved.

引用

页码：63 / 75

页数：13

共 46 条

[1] Suppression of rnyasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4+CD25+ regulatory cells [J].

Aruna, BV ;

Sela, M ;

Mozes, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (29) :10285-10290

[2] ANALYSIS OF THE BIOLOGICAL FUNCTIONS AND FINE SPECIFICITY OF (T,G)-A--L SPECIFIC T-CELL CLONES [J].

AXELROD, O ;

MOZES, E .

IMMUNOBIOLOGY, 1986, 172 (1-2) :99-109

[3] Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis [J].

Balandina, A ;

Lécart, S ;

Dartevelle, P ;

Saoudi, A ;

Berrih-Aknin, S .

BLOOD, 2005, 105 (02) :735-741

[4] Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis [J].

Ben-David, H ;

Sela, M ;

Mozes, E .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (06) :2028-2033

[5]

BROCKE S, 1990, IMMUNOLOGY, V69, P495

[6] INVITRO PROLIFERATIVE RESPONSES AND ANTIBODY-TITERS SPECIFIC TO HUMAN ACETYLCHOLINE-RECEPTOR SYNTHETIC PEPTIDES IN PATIENTS WITH MYASTHENIA-GRAVIS AND RELATION TO HLA CLASS-II GENES [J].

BROCKE, S ;

BRAUTBAR, C ;

STEINMAN, L ;

ABRAMSKY, O ;

ROTHBARD, J ;

NEUMANN, D ;

FUCHS, S ;

MOZES, E .

JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (06) :1894-1900

[7] Neuropilin-1: a surface marker of regulatory T cells [J].

Bruder, D ;

Probst-Kepper, M ;

Westendorf, AM ;

Geffers, R ;

Beissert, S ;

Loser, K ;

von Boehmer, H ;

Buer, J ;

Hansen, W .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (03) :623-630

[8] Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].

Chen, WJ ;

Jin, WW ;

Hardegen, N ;

Lei, KJ ;

Li, L ;

Marinos, N ;

McGrady, G ;

Wahl, SM .

JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886

[9] Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis [J].

Dayan, M ;

Sthoeger, Z ;

Neiman, A ;

Abarbanel, J ;

Sela, M ;

Mozes, E .

HUMAN IMMUNOLOGY, 2004, 65 (06) :571-577

[10] MEDICAL PROGRESS - MYASTHENIA-GRAVIS [J].

DRACHMAN, DB .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (25) :1797-1810

← 1 2 3 4 5 →